Metabolon Files Patent Infringement Lawsuit against Stemina
Want to listen to this article for FREE?
Complete the form below to unlock access to ALL audio articles.
Read time: Less than a minute
Metabolon, Inc., has filed a patent infringement lawsuit against Stemina Biomarker Discovery, Inc. in the US District Court for the Western District of Wisconsin.
The lawsuit seeks a ruling that Stemina’s services directly infringe on US Patent 7,550,258 and US Patent 7,910,301 which relate to global analysis of complex biological samples for the discovery of biomarkers and pathways associated with drug action, toxicity and disease.
